Investors want $2.5 billion in class action over Bayer's Monsanto deal
Reuters
Published Jan 03, 2022 12:18PM ET
Updated Jan 03, 2022 12:46PM ET
FRANKFURT (Reuters) - Investors are demanding around 2.2 billion euros ($2.5 billion) from Bayer (OTC:BAYRY) as part of a possible class action lawsuit in Germany over the takeover of U.S. seed manufacturer Monsanto (NYSE:MON), law firm Tilp said on Monday.
The law firm said that as of Dec. 30, the sum covered lawsuits from about 320 investors, both institutional and retail, that had been filed with the district court in Cologne.
This represents a significant jump from the 250-plus investors demanding damages of more than 1 billion euros that Tilp disclosed last month.
Tilp has said it believes Bayer deceived shareholders about the risks of consumer lawsuits pending in the United States linked to the weed killer Roundup, which was brought into the company with the $63 billion acquisition of Monsanto in 2016.
Bayer, in an emailed statement, said any complaints were unfounded, adding the company had complied with the law and disclosure requirements.
"In addition we are convinced that we have carried out adequate due diligence regarding the acquisition of Monsanto," Bayer said, adding it would defend itself accordingly.
In the United States, Bayer is defending itself against thousands of lawsuits by Roundup users because of the alleged carcinogenic effect of the product. Bayer has always rejected this.
($1 = 0.8857 euros)
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.